Cargando…

Reactive astrocytes associated with prion disease impair the blood brain barrier

BACKGROUND: Impairment of the blood-brain barrier (BBB) is considered to be a common feature among neurodegenerative diseases, including Alzheimer’s, Parkinson’s and prion diseases. In prion disease, increased BBB permeability was reported 40 years ago, yet the mechanisms behind the loss of BBB inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushwaha, Rajesh, Li, Yue, Makarava, Natallia, Pandit, Narayan P., Molesworth, Kara, Birukov, Konstantin G., Baskakov, Ilia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055297/
https://www.ncbi.nlm.nih.gov/pubmed/36993690
http://dx.doi.org/10.1101/2023.03.21.533684
_version_ 1785015851974393856
author Kushwaha, Rajesh
Li, Yue
Makarava, Natallia
Pandit, Narayan P.
Molesworth, Kara
Birukov, Konstantin G.
Baskakov, Ilia V.
author_facet Kushwaha, Rajesh
Li, Yue
Makarava, Natallia
Pandit, Narayan P.
Molesworth, Kara
Birukov, Konstantin G.
Baskakov, Ilia V.
author_sort Kushwaha, Rajesh
collection PubMed
description BACKGROUND: Impairment of the blood-brain barrier (BBB) is considered to be a common feature among neurodegenerative diseases, including Alzheimer’s, Parkinson’s and prion diseases. In prion disease, increased BBB permeability was reported 40 years ago, yet the mechanisms behind the loss of BBB integrity have never been explored. Recently, we showed that reactive astrocytes associated with prion diseases are neurotoxic. The current work examines the potential link between astrocyte reactivity and BBB breakdown. RESULTS: In prion-infected mice, the loss of BBB integrity and aberrant localization of aquaporin 4 (AQP4), a sign of retraction of astrocytic endfeet from blood vessels, were noticeable prior to disease onset. Gaps in cell-to-cell junctions along blood vessels, together with downregulation of Occludin, Claudin-5 and VE-cadherin, which constitute tight and adherens junctions, suggested that loss of BBB integrity is linked with degeneration of vascular endothelial cells. In contrast to cells isolated from non-infected adult mice, endothelial cells originating from prion-infected mice displayed disease-associated changes, including lower levels of Occludin, Claudin-5 and VE-cadherin expression, impaired tight and adherens junctions, and reduced trans-endothelial electrical resistance (TEER). Endothelial cells isolated from non-infected mice, when co-cultured with reactive astrocytes isolated from prion-infected animals or treated with media conditioned by the reactive astrocytes, developed the disease-associated phenotype observed in the endothelial cells from prion-infected mice. Reactive astrocytes were found to produce high levels of secreted IL-6, and treatment of endothelial monolayers originating from non-infected animals with recombinant IL-6 alone reduced their TEER. Remarkably, treatment with extracellular vesicles produced by normal astrocytes partially reversed the disease phenotype of endothelial cells isolated from prion-infected animals. CONCLUSIONS: To our knowledge, the current work is the first to illustrate early BBB breakdown in prion disease and to document that reactive astrocytes associated with prion disease are detrimental to BBB integrity. Moreover, our findings suggest that the harmful effects are linked to proinflammatory factors secreted by reactive astrocytes.
format Online
Article
Text
id pubmed-10055297
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-100552972023-03-30 Reactive astrocytes associated with prion disease impair the blood brain barrier Kushwaha, Rajesh Li, Yue Makarava, Natallia Pandit, Narayan P. Molesworth, Kara Birukov, Konstantin G. Baskakov, Ilia V. bioRxiv Article BACKGROUND: Impairment of the blood-brain barrier (BBB) is considered to be a common feature among neurodegenerative diseases, including Alzheimer’s, Parkinson’s and prion diseases. In prion disease, increased BBB permeability was reported 40 years ago, yet the mechanisms behind the loss of BBB integrity have never been explored. Recently, we showed that reactive astrocytes associated with prion diseases are neurotoxic. The current work examines the potential link between astrocyte reactivity and BBB breakdown. RESULTS: In prion-infected mice, the loss of BBB integrity and aberrant localization of aquaporin 4 (AQP4), a sign of retraction of astrocytic endfeet from blood vessels, were noticeable prior to disease onset. Gaps in cell-to-cell junctions along blood vessels, together with downregulation of Occludin, Claudin-5 and VE-cadherin, which constitute tight and adherens junctions, suggested that loss of BBB integrity is linked with degeneration of vascular endothelial cells. In contrast to cells isolated from non-infected adult mice, endothelial cells originating from prion-infected mice displayed disease-associated changes, including lower levels of Occludin, Claudin-5 and VE-cadherin expression, impaired tight and adherens junctions, and reduced trans-endothelial electrical resistance (TEER). Endothelial cells isolated from non-infected mice, when co-cultured with reactive astrocytes isolated from prion-infected animals or treated with media conditioned by the reactive astrocytes, developed the disease-associated phenotype observed in the endothelial cells from prion-infected mice. Reactive astrocytes were found to produce high levels of secreted IL-6, and treatment of endothelial monolayers originating from non-infected animals with recombinant IL-6 alone reduced their TEER. Remarkably, treatment with extracellular vesicles produced by normal astrocytes partially reversed the disease phenotype of endothelial cells isolated from prion-infected animals. CONCLUSIONS: To our knowledge, the current work is the first to illustrate early BBB breakdown in prion disease and to document that reactive astrocytes associated with prion disease are detrimental to BBB integrity. Moreover, our findings suggest that the harmful effects are linked to proinflammatory factors secreted by reactive astrocytes. Cold Spring Harbor Laboratory 2023-03-24 /pmc/articles/PMC10055297/ /pubmed/36993690 http://dx.doi.org/10.1101/2023.03.21.533684 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Kushwaha, Rajesh
Li, Yue
Makarava, Natallia
Pandit, Narayan P.
Molesworth, Kara
Birukov, Konstantin G.
Baskakov, Ilia V.
Reactive astrocytes associated with prion disease impair the blood brain barrier
title Reactive astrocytes associated with prion disease impair the blood brain barrier
title_full Reactive astrocytes associated with prion disease impair the blood brain barrier
title_fullStr Reactive astrocytes associated with prion disease impair the blood brain barrier
title_full_unstemmed Reactive astrocytes associated with prion disease impair the blood brain barrier
title_short Reactive astrocytes associated with prion disease impair the blood brain barrier
title_sort reactive astrocytes associated with prion disease impair the blood brain barrier
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055297/
https://www.ncbi.nlm.nih.gov/pubmed/36993690
http://dx.doi.org/10.1101/2023.03.21.533684
work_keys_str_mv AT kushwaharajesh reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier
AT liyue reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier
AT makaravanatallia reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier
AT panditnarayanp reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier
AT molesworthkara reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier
AT birukovkonstanting reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier
AT baskakoviliav reactiveastrocytesassociatedwithpriondiseaseimpairthebloodbrainbarrier